论文信息 - Nivolumab with carboplatin, paclitaxel, and bevacizumab for first-line treatment of advanced non-squamous non-small cell lung cancer. - 字舞流文

Nivolumab with carboplatin, paclitaxel, and bevacizumab for first-line treatment of advanced non-squamous non-small cell lung cancer.

M. Nishio | N. Yamamoto | T. Tamura | K. Nakagawa | T. Hida | S. Sugawara | J. Lee | Y. Namba | C. Yu | J. Kang | H. Kim | N. Sumiyoshi | K. Lee | N. Inui | T. Yoshida | H. Tanaka | C. Yang | Y. Ohe | H. Akamatsu | C. Yu | C. Yu